The global single cell analysis market size is expected to reach USD 8.02 billion by 2027, registering a CAGR of 16.9% during the forecast period, according to a new report by Grand View Research, Inc. Advancements in molecular techniques which resulted in higher accuracy, ability to perform multiple omics analyses in one cell, and automation, has lowered the barriers for implementation of single-cell analysis techniques across various end-use settings. As a result, companies are investing in introducing novel solutions to accelerate the identification and quantification of genetic information in individual cells for research programs, thereby contributing to revenue growth in this market.
This
technology has addressed several research challenges with respect to biological
intricacies in stem cell biology, tumor biology, immunology, and other
therapeutic areas. This leads to improved therapeutic decision-making with
regards to precision medicine, thereby driving the adoption of these assays in
personalized therapeutic development.
The
growth in research publications depicts the increasing R&D investments.
Since R&D activities are considered as the foundation of innovation,
investments in R&D activities signify a healthy growth prospect for the
single cell analysis market. Moreover, the establishment of new single cell
genomics centers in the past years is anticipated to boost the uptake of
instruments and consumables for single cell analysis, thus driving the growth.
Full Research Report On Single Cell Analysis Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
Further key
findings from the report suggest:
- Consumables accounted for
the major revenue share in 2019 owing to the continuous demand and
repeated purchase of products offered under this segment
- Introduction of automated
instruments is anticipated to boost the revenue growth for instrument
segment
- Cancer biology is one of the
majorly benefitted applications of single-cell analysis
- Investigation at the
individual cellular level has resolved several concerns associated with
tumor mechanism and drug response, which has fomented the uptake of this
technology analysis in cancer biology
- Single cell analysis is
being researched and employed across various end-use settings ranging from
academic research institutes to biopharmaceutical companies
- However, since it is in
infant stage in the current mark, majorly it is employed with research
end-user settings
- Hospitals and diagnostic
laboratories segment is expected to emerge as the lucrative source of
revenue in the forthcoming years, due to the ongoing efforts to bridge the
gap for implementation of OMICs technology from research laboratories to
clinical settings
- North America dominated the
global revenue share in 2019, owing to the continuous strategies
undertaken in U.S. for development of robust therapies and advance the
disease diagnosis
- Asia Pacific is estimated to
expand at the fastest CAGR over the forecast period with China & India
at the forefront. A high number of CAR T clinical trials in China and low
operating cost for clinical trials in India would contribute to the
anticipated growth
- Some key players operating
in the Single cell analysis market are Illumina, Inc.; Qiagen N.V.; Thermo
Fisher Scientific, Inc.; Merck Millipore GmbH; Bio-Rad Laboratories, Inc.;
Fluidigm, BGI; 10x Genomics, Inc.; and Novogene Corporation
- Companies like Illumina and
Qiagen are expected to gain competitive advantage on account of their wide
sequencing portfolio. On the other hand, companies like 10x Genomics, Inc.
are anticipated to witness significant organic revenue growth owing to
wide product portfolio
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request/rs1
Grand View Research has segmented
the global single cell analysis market on the basis of product, application,
end use, and region:
Single-cell
Analysis Product Outlook (Revenue, USD Million, 2016 - 2027)
- Consumables
- Reagents
- Assay Kits
- Other Consumables
- Instruments
- Manual Instruments
- Microscopes
- Hemocytometers
- Automated Instruments
- Flow cytometers
- Next Generation Sequencing
- PCR Systems
- High-content Screening
System
- Cell Microarrays
- Automated Cell Counters
Single-cell
Analysis Application Outlook (Revenue, USD Million, 2016 - 2027)
- Cancer
- Immunology
- Neurology
- Stem Cell
- Non-invasive Prenatal
Diagnosis
- In-vitro Fertilization
Single-cell
Analysis End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Academic & Research
Laboratories
- Biotechnology and
Pharmaceutical Companies
- Hospitals and Diagnostic
Laboratories
- Others
Single-cell
Analysis Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment